Tesamorelin TSM10 (10mg x 10 vials) is the ultimate flagship product in the TSM series of modified GHRH analog research peptides, representing a top-tier, saturated upgrade of TSM2 and intermediate-potency TSM5. Utilizing industry-leading structural optimization and full-molecule activity enhancement technologies, it retains Tesamorelin's core advantages—anti-enzymatic degradation and dual-targeting of visceral-liver lipid metabolism—while maximizing pathway binding affinity and endocrine activation intensity. With a saturation concentration upper limit of 10mg, TSM10 provides comprehensive lipolysis efficacy and extremely strong metabolic remodeling capabilities, completely overcoming the efficacy limitations of low- and medium-dose TSM variants. Specifically designed for ultra-high dose gradient threshold studies, high-intensity visceral fat ablation, metabolic reversal of severe fatty liver, intervention for extreme insulin resistance, and validation of high-standard complex peptide synergistic effects, it is a top-tier core research material for high-end preclinical studies targeting refractory lipid metabolism disorders and advanced age-related lipodystrophy.
Product Functions and Research Value
In advanced laboratory studies, Tesamorelin TSM10 can trigger saturated, high-amplitude physiological pulsatile growth hormone (GH) secretion and sustained upregulation of peak levels of insulin-like growth factor-1 (IGF-1), fully activating deep mitochondrial lipid oxidation and catabolism and systemic lipid transport pathways. Unlike the mild basal effect of TSM2 and the balanced moderate efficacy of TSM5, TSM10 reaches the upper limit in severe and extreme visceral fat breakdown, liver lipid deposition clearance, comprehensive relief of lipid inflammation, and improvement of high-threshold insulin sensitivity. It can completely reverse severe visceral fat accumulation, advanced fatty liver metabolic disorders, and refractory lipid metabolism imbalances, while exerting a powerful anti-aging endocrine repair and high-density lean tissue maintenance effect. Strictly following natural physiological rhythms for activation, it does not cause feedback inhibition or long-term receptor desensitization, and can maintain stable endocrine homeostasis even under high-intensity, long-term intervention. TSM10 is an ideal choice for cutting-edge metabolic mechanism research, extreme dose gradient screening, and validation of high-quality peptide combination regimens. It offers highly significant phenotypic differentiation and authoritative, comprehensive data support for in-depth exploration of extreme intervention mechanisms targeting lipid metabolism and metabolic syndrome.
Core Product Advantages
1. TSM10 Ultimate All-Around Flagship Upgrade: The pinnacle of the TSM series, with fully optimized molecular structure and target activity. It inherits 100% of Tesamorelin's unique lipid-targeting properties while maximizing the intensity of metabolic intervention, achieving the highest efficacy level among modified GHRH lipid-regulating peptides.
2. Visceral and Hepatic Lipid Clearance Reaches Maximum Limits: Building upon the efficacy of intermediate doses, it further enhances deep fat and liver pathway activation, thoroughly clearing stubborn visceral fat and severe hepatic lipid deposits. It addresses the core pain point of insufficient improvement in mild to moderate metabolic disorders in low- and intermediate-dose versions.
3. Ultra-Stable Modified Molecular System: Mature enhanced structural modifications provide extremely strong anti-degradation and anti-metabolic stability, supporting long-term, high-intensity chronic metabolic interventions. It outputs ultra-sustainable and stable lipid regulation signals, free from hormonal fluctuations or endocrine interference, ensuring the stability of long-term extreme modeling data. 4. 10mg Saturation Upper Limit Specification: Top-tier flagship concentration, twice the potency of TSM5 and five times that of TSM2. Perfectly suited for ultra-high-dose extreme gradient experiments, interventions for refractory metabolic disorders, and high-standard complex peptide synergistic studies, covering high-threshold research scenarios that low- and medium-dose versions cannot support. 5. Pharmaceutical-grade Superior Quality Assurance: Employs advanced aseptic vacuum freeze-drying technology to completely lock in the peptide's peak intrinsic activity. Each batch undergoes comprehensive HPLC high-purity testing and comes with a complete official COA certificate. Standard 10-bottle aseptic integrated packaging meets the needs of cutting-edge research in high-end laboratories, national key metabolic science projects, top-tier drug preclinical development, and global high-end bulk wholesale procurement.
Tesamorelin TSM10 10mg*10 bottles is the ultimate flagship product.